-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Axim Biotechnologies, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2013 to Q2 2024.
- Axim Biotechnologies, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -0.01 USD/shares, a 50% increase year-over-year.
- Axim Biotechnologies, Inc. Earnings Per Share, Diluted for the twelve months ending June 30, 2024 was -0.02 USD/shares, a 66.7% increase year-over-year.
- Axim Biotechnologies, Inc. annual Earnings Per Share, Diluted for 2023 was -0.04 USD/shares, unchanged from 2022.
- Axim Biotechnologies, Inc. annual Earnings Per Share, Diluted for 2022 was -0.04 USD/shares, a 133% decline from 2021.
- Axim Biotechnologies, Inc. annual Earnings Per Share, Diluted for 2021 was 0.12 USD/shares.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)